Codagenix Stock
Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
Sign up today and learn more about Codagenix Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Codagenix Stock
Codagenix is a developer of live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus. Its vaccines utilize Synthetic Attenuated Virus Engineering (SAVE), which are based on synthetic biology and are rationally re-designed of the entire genome to yield a vaccine strain.
Investors
U.S. Department of Defense
Funding History
| July 2012 | $600K |
|---|---|
| June 2014 | $1.2M |
| December 2014 | $100K |
| June 2015 | $2.0M |
| October 2017 | $3.0M |
| April 2019 | $1.0M |
| January 2020 | $20.0M |
| July 2020 | $2.2M |
| August 2022 | $4.4M |
| February 2023 | $25.0M |
Management
Chief Medical Officer
Sybil Tasker
Chief Business Officer
Jeffrey Fu
Member Board Of Director
Jill Howe
Co-Founder & President, Chief Scientific Officer
Steffen Mueller
CFO
Tyler Cook
Co-Founder & Senior Scientific Advisor
Eckard Wimmer
Chief Strategy Officer
Kimber Poffenberger
EVP of Animal Health
Bruce E. Taillon
Co-Founder & Chief Executive Officer
J. Robert Coleman
Press
biospace - Mar, 28 2023
Codagenix Announces Appointment of Kimber Poffenberger, Ph.D., as Chief Strategy Officerprnewswire - Jan, 12 2022
Codagenix Welcomes Bruce Taillon as Executive Vice President of Animal Healthprnewswire - Aug, 26 2021
Codagenix Appoints Tyler Cook as Chief Financial Officernews - Dec, 15 2020
It’s Full Steam Ahead For Startups Developing COVID-19 Vaccines And Productspharmiweb - Oct, 28 2020
Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officerafr - Feb, 28 2020
Jim Simons-backed Codagenix is developing a coronavirus vaccineEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
